PROOF-HIT
DEAD

Serial Number

78022514

Owner

ExonHit Therapeutics SA

Attorney

Martin Savitzky

Filing Date

Aug 23, 2000

Add to watchlist:

No watchlists yet
View on USPTO

PROOF-HIT Trademark

Serial Number: 78022514

PROOF-HIT is a trademark filed by ExonHit Therapeutics SA on August 23, 2000. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ExonHit Therapeutics SA (11 trademarks)

65 Boulevard Massena
Paris 75013 , FR

Entity Type: 03

Trademark Details

Filing Date

August 23, 2000

Registration Date

Not Registered

Published for Opposition

October 19, 2004

Goods & Services

Computer programs for medical testing, to analyze nucleic acids present in human or animal cells, using nucleic acid arrays on filters or chips and chemical reagents, to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases

Nucleic acid arrays on filters or chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases; chemical reagents for medical use

Nucleic acid probes on filters or chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases

Medical testing services for analysis of nucleic acids found in human or animal cells to determine the presence of pathologies, namely, cancer and neurodegenerative diseases, or the effect of drugs on such pathologies, namely, cancer and neurodegenerative diseases

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 3, 2005 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 30, 2005 ABN6
UNDELIVERABLE MAIL - COURTESY COPY MAILED
Sep 20, 2005 UNDC
PAPER RECEIVED
May 5, 2005 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 11, 2005 NOAM
PAPER RECEIVED
Nov 12, 2004 MAIL
PUBLISHED FOR OPPOSITION
Oct 19, 2004 PUBO
PAPER RECEIVED
Sep 29, 2004 MAIL
NOTICE OF PUBLICATION
Sep 29, 2004 NPUB
PAPER RECEIVED
Sep 22, 2004 MAIL
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 17, 2004 PREV
ASSIGNED TO LIE
Aug 17, 2004 ALIE
ASSIGNED TO LIE
Aug 17, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2004 CNSA
CASE FILE IN TICRS
Oct 7, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2003 CRFA
PAPER RECEIVED
Aug 25, 2003 MAIL
NON-FINAL ACTION MAILED
Feb 25, 2003 CNRT
ASSIGNED TO EXAMINER
Feb 25, 2003 DOCK
PAPER RECEIVED
Dec 27, 2002 MAIL
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 23, 2002 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2002 CNSA
NON-FINAL ACTION E-MAILED
Jun 25, 2002 GNRT
NON-FINAL ACTION E-MAILED
Jun 12, 2002 GNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2002 CRFA
PAPER RECEIVED
Mar 18, 2002 MAIL
NON-FINAL ACTION MAILED
Sep 27, 2001 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2001 CRFA
NON-FINAL ACTION MAILED
Feb 13, 2001 CNRT
ASSIGNED TO EXAMINER
Feb 12, 2001 DOCK
ASSIGNED TO EXAMINER
Feb 6, 2001 DOCK